Nuvectis Pharma, Inc. (NVCT)
NASDAQ: NVCT · Real-Time Price · USD
7.59
+0.01 (0.13%)
At close: Dec 12, 2025, 4:00 PM EST
7.59
0.00 (0.00%)
After-hours: Dec 12, 2025, 4:00 PM EST
Nuvectis Pharma Market Cap
Nuvectis Pharma has a market cap or net worth of $194.93 million as of December 12, 2025. Its market cap has increased by 103.82% in one year.
Market Cap
194.93M
Enterprise Value
161.28M
1-Year Change
103.82%
Ranking
Category
Stock Price
$7.59
Market Cap Chart
Since the IPO on February 4, 2022, Nuvectis Pharma's market cap has increased from $58.01M to $194.93M, an increase of 236.05%. That is a compound annual growth rate of 36.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 11, 2025 | 194.16M | 85.75% |
| Dec 31, 2024 | 104.53M | -27.67% |
| Dec 29, 2023 | 144.50M | 31.58% |
| Dec 30, 2022 | 109.82M | 89.32% |
| Feb 4, 2022 | 58.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 889.69B |
| Johnson & Johnson | 497.62B |
| AbbVie | 397.98B |
| UnitedHealth Group | 297.45B |
| AstraZeneca | 279.37B |
| Novartis AG | 251.91B |
| Merck & Co. | 242.30B |
| Thermo Fisher Scientific | 215.59B |